Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Clicks: 494
ID: 270484
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 2 articles by views in The Lancet. Oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
European Myeloma Network and Janssen Research and Development.
Reference Key
ma2021thedaratumumab Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dimopoulos MA;Terpos E;Boccadoro M;Delimpasi S;Beksac M;Katodritou E;Moreau P;Baldini L;Symeonidis A;Bila J;Oriol A;Mateos MV;Einsele H;Orfanidis I;Ahmadi T;Ukropec J;Kampfenkel T;Schecter JM;Qiu Y;Amin H;Vermeulen J;Carson R;Sonneveld P; ;;
Journal The Lancet. Oncology
Year 2021
DOI
DOI not found
URL
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male aged middle aged Clinical Trial Phase III Randomized Controlled Trial Antibodies Proportional Hazards Models neutropenia / chemically induced monoclonal / adverse effects neoplasm recurrence local / pathology antineoplastic combined chemotherapy protocols / adverse effects antineoplastic combined chemotherapy protocols / administration & dosage neutropenia / pathology Progression-Free Survival initials='g' affs=[] is_editor=false suffix=none equal_contrib=false) initials='j' initials='a' initials='h' initials='ma' initials='b' initials='n' initials='p' initials='l' initials='d' affs=[]) initials='s' initials='m' initials='f' initials='c' author(firstnames='philippe' author(firstnames='ali' initials='r' author(firstnames='roberto' initials='e' initials='t' author(firstnames='stefan' author(firstnames='hans' author(firstnames='mario' author(firstnames='javier' author(firstnames='xavier' initials='x' author(firstnames='juan josé' initials='jj' author(firstnames='sebastián' author(firstnames='carmen' author(firstnames='pieter' initials='mc' initials='mv' equal_contrib=false)] author(firstnames='brian' meletios a dimopoulos lastname='doyen' lastname='meuleman' lastname='wu' lastname='engelhardt' lastname='goldschmidt' lastname='knop' lastname='foa' lastname='zweegman' multiple myeloma / drug therapy* thalidomide / administration & dosage thalidomide / adverse effects thalidomide / analogs & derivatives* pmid:34087126 doi:10.1016/s1470-2045(21)00128-5 evangelos terpos collabauthor(name='apollo trial investigators' investigators=[author(firstnames='adrian' lastname='alegre amor' author(firstnames='luca' lastname='baldini' author(firstnames='meral' lastname='beksac' author(firstnames='angelo' lastname='belotti' author(firstnames='lotfi' lastname='benboubker' author(firstnames='britta' lastname='besemer' author(firstnames='sevgi' lastname='besisik' author(firstnames='jelena' lastname='bila' lastname='boccadoro' author(firstnames='michele' lastname='cavo' lastname='de la rubia comos' author(firstnames='sosana' lastname='delimpasi' author(firstnames='meletios a' lastname='dimopoulos' author(firstnames='chantal' author(firstnames='dominik' lastname='dytfeld' author(firstnames='monika' author(firstnames='thierry' lastname='facon' author(firstnames='hartmut' lastname='grosicki' author(firstnames='roman' lastname='hajek' author(firstnames='guner' lastname='hayri ozsan' author(firstnames='cyrille' lastname='hulin' lastname='iversen' author(firstnames='lionel' lastname='karlin' author(firstnames='eirini' lastname='katodritou' author(firstnames='marie-christine' lastname='kyrtsonis' lastname='lahuerta' lastname='leleu' lastname='martinez chamorro' author(firstnames='maría-victoria' lastname='mateos manteca' author(firstnames='nathalie' author(firstnames='monique' lastname='minnema' lastname='moreau' author(firstnames='massino' lastname='offidani' author(firstnames='albert' lastname='oriol rocafiguera' author(firstnames='mustafa' lastname='pehlivan' author(firstnames='ludek' lastname='pour' author(firstnames='henk th j' lastname='roerdink' initials='htj' author(firstnames='laura' lastname='rosinol dacsh' lastname='salwender' lastname='sonneveld' author(firstnames='anargyros' lastname='symeonidis' author(firstnames='charlotte' lastname='toftmann hansen' author(firstnames='tulin' lastname='tuglular' lastname='unal' author(firstnames='philip' lastname='vlummens' author(firstnames='filiz' lastname='vural' author(firstnames='ka lung' initials='kl' author(firstnames='sonja' monoclonal / administration & dosage* dexamethasone / administration & dosage* dexamethasone / adverse effects multiple myeloma / pathology local / drug therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.